Compare
P3 Health Partners Inc. vs LifeStance Health Group, Inc. vs Privia Health Group, Inc. vs InnovAge Holding Corp.
| Latest fiscal year | P3 Health Partners Inc. PIII | LifeStance Health Group, Inc. LFST | Privia Health Group, Inc. PRVA | InnovAge Holding Corp. INNV |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2026-06-30 |
| Revenue | $1.46B | $1.42B | $2.12B | $989.71M |
| Revenue growth (YoY) | -2.8% | +13.9% | +22.3% | +15.9% |
| Gross margin | n/a | n/a | n/a | 23.0% |
| Operating margin | -18.5% | 1.7% | 1.6% | 0.3% |
| Net margin | -10.1% | 0.7% | 1.1% | -0.3% |
| Net income | -$147.95M | $9.66M | $22.92M | -$2.54M |
| EPS (Diluted) | -$45.26 | n/a | $0.18 | -$0.02 |
| Operating cash flow | -$91.24M | $146.15M | $163.40M | $64.71M |
| Free cash flow | n/a | $110.03M | n/a | $50.41M |
| Cash & equivalents | $25.01M | $248.64M | $479.69M | $97.89M |
| Total assets | $656.64M | $2.20B | $1.37B | $557.39M |
| Total liabilities | $796.88M | $682.92M | $578.43M | $288.62M |
| Shareholders' equity | -$155.23M | $1.52B | $790.94M | $235.60M |
| Return on year-end equity | n/a | 0.6% | 2.9% | -1.1% |
| Shares outstanding | n/a | 388.32M | 123.60M | 136.02M |
Revenue, most recent five fiscal years
| Fiscal year | P3 Health Partners Inc. | LifeStance Health Group, Inc. | Privia Health Group, Inc. | InnovAge Holding Corp. |
|---|---|---|---|---|
| Latest | $1.46B Ended 2025-12-31 | $1.42B Ended 2025-12-31 | $2.12B Ended 2025-12-31 | $989.71M Ended 2026-06-30 |
| 1 year earlier | $1.50B Ended 2024-12-31 | $1.25B Ended 2024-12-31 | $1.74B Ended 2024-12-31 | $853.70M Ended 2025-06-30 |
| 2 years earlier | $1.27B Ended 2023-12-31 | $1.06B Ended 2023-12-31 | $1.66B Ended 2023-12-31 | $763.86M Ended 2024-06-30 |
| 3 years earlier | $1.05B Ended 2022-12-31 | $859.54M Ended 2022-12-31 | $1.36B Ended 2022-12-31 | $688.09M Ended 2023-06-30 |
| 4 years earlier | n/a | $667.51M Ended 2021-12-31 | $966.22M Ended 2021-12-31 | $698.64M Ended 2022-06-30 |